Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SMPD1 | P17405 | 4/20 | 0.62 |
| ▸ | HDAC1 | Q13547 | 1/20 | 0.61 |
| ▸ | HDAC8 | Q9BY41 | 1/20 | 0.61 |
| ▸ | HDAC6 | Q9UBN7 | 1/20 | 0.61 |
| ▸ | BCL2L1 | Q07817 | 4/20 | 0.60 |
| ▸ | MCL1 | Q07820 | 4/20 | 0.60 |
| ▸ | NR1H4 | Q96RI1 | 3/20 | 0.58 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.57 |
| ▸ | GAA | P10253 | 1/20 | 0.57 |
| ▸ | TSHR | P16473 | 1/20 | 0.57 |
| ▸ | MEN1 | O00255 | 2/20 | 0.56 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.56 |
| ▸ | NR4A2 | P43354 | 1/20 | 0.54 |
| ▸ | MAOB | P27338 | 1/20 | 0.52 |
| ▸ | GPR132 | Q9UNW8 | 1/20 | 0.52 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7045604 | 0.99 | SMPD1 (0.61) | SMPD1HDAC1HDAC8HDAC6BCL2L1 | |
| SCHEMBL7076910 | 0.96 | HDAC1 (0.59) | SMPD1HDAC1HDAC8HDAC6BCL2L1 | |
| SCHEMBL7045371 | 0.93 | KMT2A (0.62) | SMPD1HDAC1HDAC8HDAC6BCL2L1 | |
| SCHEMBL7083454 | 0.92 | SMPD1 (0.54) | SMPD1HDAC1HDAC8HDAC6BCL2L1 | |
| SCHEMBL7077932 | 0.92 | HDAC1 (0.58) | SMPD1HDAC1HDAC8HDAC6BCL2L1 | |
| SCHEMBL7049781 | 0.92 | SMPD1 (0.61) | SMPD1HDAC1HDAC8HDAC6BCL2L1 | |
| SCHEMBL7081001 | 0.92 | HDAC1 (0.56) | SMPD1HDAC1HDAC8HDAC6BCL2L1 | |
| SCHEMBL7082518 | 0.92 | SMPD1 (0.54) | SMPD1HDAC1HDAC8HDAC6BCL2L1 | |
| SCHEMBL7044608 | 0.92 | SMPD1 (0.53) | SMPD1HDAC1HDAC8HDAC6BCL2L1 | |
| SCHEMBL7047751 | 0.92 | SMPD1 (0.55) | SMPD1HDAC1HDAC8HDAC6BCL2L1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20030191323-A1 | Hypoglycemic agent | AJINOMOTO CO., INC. (JP) | 2003-10-09 | — | — | US | disclosed |
| US-20030162818-A1 | Acylsulfonamide derivative | AJINOMOTO CO. INC. (JP) | 2003-08-28 | — | — | US | disclosed |
| US-6555584-B1 | Acetyl-coa carboxylase inhibitors | AJINOMOTO CO., INC. (JP) | 2003-04-29 | — | — | US | disclosed |
| EP-1300142-A1 | HYPOGLYCEMICS | Ajinomoto Co., Inc. (JP) | 2003-04-09 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20030162818-A1 | Acylsulfonamide derivative | ACSS2, ACACA, FASN | SMPD1 760/4885HDAC1 271/4885HDAC8 1064/4885 |
| US-20030191323-A1 | Hypoglycemic agent | GPR119, IAPP, SLC5A2 | SMPD1 156/4885HDAC1 305/4885HDAC8 293/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.